Literature DB >> 16785646

High-throughput affinity mass spectrometry.

Urban A Kiernan1, Dobrin Nedelkov, Eric E Niederkofler, Kemmons A Tubbs, Randall W Nelson.   

Abstract

Affinity mass spectrometry (AMS) is a proteomics approach for selectively isolating target protein(s) from complex biological fluids for mass spectrometric analysis. The resulting high-content mass spectrometry (MS) data show the unique MS protein signatures (wild-type, posttranslationally modified, as well as genetically modified forms of the protein target) that are present within a biological sample. Information regarding such protein diversity is normally lost in classical proteomic or immunoassay analyses. This chapter presents a step-by-step description of high-throughput AMS in the population proteomic screening of the human plasma protein cystatin C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785646     DOI: 10.1385/1-59745-026-X:141

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  MALDI-target integrated platform for affinity-captured protein digestion.

Authors:  Asilah Ahmad-Tajudin; Belinda Adler; Simon Ekström; György Marko-Varga; Johan Malm; Hans Lilja; Thomas Laurell
Journal:  Anal Chim Acta       Date:  2013-09-11       Impact factor: 6.558

2.  Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity.

Authors:  Chad R Borges; Paul E Oran; Sai Buddi; Jason W Jarvis; Matthew R Schaab; Douglas S Rehder; Stephen P Rogers; Thomas Taylor; Randall W Nelson
Journal:  Clin Chem       Date:  2011-03-14       Impact factor: 8.327

3.  Possibilities and pitfalls in quantifying the extent of cysteine sulfenic acid modification of specific proteins within complex biofluids.

Authors:  Douglas S Rehder; Chad R Borges
Journal:  BMC Biochem       Date:  2010-07-01       Impact factor: 4.059

4.  Glycosylation status of vitamin D binding protein in cancer patients.

Authors:  Douglas S Rehder; Randall W Nelson; Chad R Borges
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

Review 5.  Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Authors:  Hussein Yassine; Chad R Borges; Matthew R Schaab; Dean Billheimer; Craig Stump; Peter Reaven; Serrine S Lau; Randall Nelson
Journal:  Proteomics Clin Appl       Date:  2013-07-09       Impact factor: 3.494

Review 6.  Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Proteomes       Date:  2016-03-17

Review 7.  Targeting RNA structures with small molecules.

Authors:  Jessica L Childs-Disney; Xueyi Yang; Quentin M R Gibaut; Yuquan Tong; Robert T Batey; Matthew D Disney
Journal:  Nat Rev Drug Discov       Date:  2022-08-08       Impact factor: 112.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.